Beyond the Abstract - Urodynamic effects of silodosin, a new alpha(1A)-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia, by Tomonori Yamanishi, MD
BERKELEY, CA (UroToday.com) - Silodosin is a newly developed α1A-adrenoceptor(AR) selective antagonist.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence
Privacy Policy | © 2010 UroToday ® All Rights Reserved |





